Answer
Its licensed use is limited to cholangiocarcinoma with an FGFR2 fusion or rearrangement, so an appropriate tumour test must confirm this alteration.
Sources for this answer
- Lytgobi 4 mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.